Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXACT SCIENCES CORP Director's Dealing 2018

Jan 4, 2018

30597_dirs_2018-01-04_39ab4db3-a04e-470b-8b48-8160de8d25e6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXACT SCIENCES CORP (EXAS)
CIK: 0001124140
Period of Report: 2018-01-02

Reporting Person: COWARD D SCOTT (SVP and General Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-10-31 Common Stock A 1682 $5.95 Acquired 37558 Direct
2018-01-02 Common Stock M 4687 $0.00 Acquired 42245 Direct
2018-01-03 Common Stock S 1665 $52.537 Disposed 40580 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-01-02 Restricted Stock Units $ M 4687 Disposed Common Stock (4687) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 3363 Indirect

Footnotes

F1: Represents shares purchased through Employee Stock Purchase Plan.

F2: Represents shares of common stock received upon vesting of a restricted stock unit award on December 31, 2017 and delivered on January 2, 2018.

F3: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on December 31, 2017.

F4: Each restricted stock unit represents a contingent right to receive one share of common stock.

F5: Represents a restricted stock unit award granted on January 1, 2015 that partially vested on December 31, 2017 and which shares were delivered on January 2, 2018. The restricted stock units vest as follows: one-quarter on the first anniversary of the grant date and the balance in equal quarterly installments over the three year period beginning on the one-year anniversary of the grant date.